Pure Financial Advisors’s Medtronic MDT Stock Holding History

Pure Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$224K	Buy	2,860 +437	+18%	+$35.3K	﹤0.01%	576
2026 Q1	$210K	Sell	2,423 -88	-4%	-$8.43K	﹤0.01%	536
2025 Q4	$241K	Sell	2,511 -132	-5%	-$12.8K	﹤0.01%	469
2025 Q3	$252K	Buy	+2,643	New	+$243K	﹤0.01%	435
2019 Q3	–	Sell	-3,416	Closed	-$333K	–	131
2019 Q2	$333K	Sell	3,416 -198	-5%	-$18.1K	0.06%	106
2019 Q1	$329K	Buy	3,614 +1	+0%	+$90	0.06%	108
2018 Q4	$329K	Buy	3,613 +7	+0.2%	+$654	0.07%	107
2018 Q3	$355K	Buy	+3,606	New	+$333K	0.08%	104

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Pure Financial Advisors's MDT Position: Q2 2026 in Review

Pure Financial Advisors increased its Medtronic (MDT) stake by 18% in Q2 2026, buying an estimated $35.3K and bringing the position to 2,860 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #576.

Pure Financial Advisors first reported a position in MDT in Q3 2018 and has held it in 8 quarters since. The position peaked at $355K in Q3 2018. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Pure Financial Advisors held 2,860 shares of Medtronic worth $224K as of Q2 2026.
Pure Financial Advisors bought 437 Medtronic shares in Q2 2026, an estimated $35.3K.
Medtronic made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #576 holding.
Pure Financial Advisors first reported a position in Medtronic in Q3 2018 and has held it in 8 quarters since.
Pure Financial Advisors's Medtronic position peaked at $355K in Q3 2018.
2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.